Genopathy
Gene-Disorder Association · Article
Gene
SOD2
Superoxide Dismutase 2
Approved treatment annotated
Association Review

In brief

The association between SOD2 (Superoxide Dismutase 2) and Lung Non-Small Cell Carcinoma is reported, supported by a single source.

Sources 1
Clinical variants 0
Symptoms 0
Compounds 2
Trials 1,062of 5,345 via SOD2 compounds
Publications 1
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
SOD2

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Lung Non-Small Cell Carcinoma

The disorder

6 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Interventions

Therapeutics

2 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
06
Human studies

Clinical trials

5,345 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
07
Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
08
Provenance

References & sources

5 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access